Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	sodium-independent organic anion transmembrane transporter activity	SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	5.80e-08	18	120	5	GO:0015347
GeneOntologyMolecularFunction	prostaglandin transmembrane transporter activity	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	1.19e-06	14	120	4	GO:0015132
GeneOntologyMolecularFunction	icosanoid transmembrane transporter activity	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	1.61e-06	15	120	4	GO:0071714
GeneOntologyMolecularFunction	arginase activity	ARG1 ARG2	1.07e-04	3	120	2	GO:0004053
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC25A24 SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLC26A7 SLCO2A1 GRIN3B	3.97e-04	293	120	8	GO:0008514
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC25A24 SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLC44A5 SLC26A7 SLCO2A1	4.25e-04	296	120	8	GO:0015291
GeneOntologyMolecularFunction	beta-catenin binding	SETD1A CDH22 FOXO4 CDH2 CDH4	7.92e-04	120	120	5	GO:0008013
GeneOntologyMolecularFunction	lipid transmembrane transporter activity	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	9.81e-04	73	120	4	GO:0170055
GeneOntologyMolecularFunction	calcium channel activity	PKD1L1 CACHD1 PKDREJ CACNG8 GRIN3B	1.10e-03	129	120	5	GO:0005262
GeneOntologyMolecularFunction	bile acid transmembrane transporter activity	SLCO2B1 SLCO1B3 SLCO1B1	1.11e-03	34	120	3	GO:0015125
GeneOntologyBiologicalProcess	sodium-independent organic anion transport	SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	1.76e-08	15	120	5	GO:0043252
GeneOntologyBiologicalProcess	head development	SOX6 SETD1A DMXL2 ESR2 WLS PLXNB2 CIC BRCA2 SGPL1 SLIT3 PAX2 FGFR3 UTP3 CDH2 TRAPPC9 PLXNA2 RBFOX2 FOXC1	6.05e-06	919	120	18	GO:0060322
GeneOntologyBiologicalProcess	brain development	SOX6 SETD1A DMXL2 ESR2 WLS PLXNB2 CIC BRCA2 SLIT3 PAX2 FGFR3 UTP3 CDH2 TRAPPC9 PLXNA2 RBFOX2 FOXC1	9.86e-06	859	120	17	GO:0007420
GeneOntologyBiologicalProcess	central nervous system development	SOX6 SETD1A DMXL2 ESR2 LAMB2 MDGA2 WLS PLXNB2 CIC BRCA2 GLIS2 SLIT3 PAX2 FGFR3 UTP3 CDH2 TRAPPC9 PLXNA2 RBFOX2 FOXC1	1.83e-05	1197	120	20	GO:0007417
GeneOntologyBiologicalProcess	pigment catabolic process	SLCO2B1 SLCO1B3 SLCO1B1	3.06e-05	11	120	3	GO:0046149
GeneOntologyBiologicalProcess	heme catabolic process	SLCO2B1 SLCO1B3 SLCO1B1	3.06e-05	11	120	3	GO:0042167
GeneOntologyBiologicalProcess	arginine catabolic process to ornithine	ARG1 ARG2	3.36e-05	2	120	2	GO:0019547
GeneOntologyBiologicalProcess	ornithine metabolic process	AZIN1 ARG1 ARG2	4.07e-05	12	120	3	GO:0006591
GeneOntologyBiologicalProcess	porphyrin-containing compound catabolic process	SLCO2B1 SLCO1B3 SLCO1B1	5.26e-05	13	120	3	GO:0006787
GeneOntologyBiologicalProcess	tetrapyrrole catabolic process	SLCO2B1 SLCO1B3 SLCO1B1	6.67e-05	14	120	3	GO:0033015
GeneOntologyBiologicalProcess	regulation of L-arginine import across plasma membrane	ARG1 ARG2	1.00e-04	3	120	2	GO:1905541
GeneOntologyBiologicalProcess	non-proteinogenic amino acid metabolic process	DAO AZIN1 ARG1 ARG2 MTHFD1	1.55e-04	87	120	5	GO:0170041
GeneOntologyBiologicalProcess	cell morphogenesis	SOX6 FGD2 ADGRB3 LAMB2 WLS PLXNB2 TBCCD1 FAM171A1 CDH22 HMCN2 SLIT3 PAX2 FGFR3 FERMT2 CDH2 CDH4 PLXNA2 RBFOX2	1.85e-04	1194	120	18	GO:0000902
GeneOntologyBiologicalProcess	organic anion transport	SLC25A24 SLCO2B1 SLCO1B3 CPT1B SLCO1B1 ARG1 ARG2 SLCO5A1 SLC26A7 SLCO2A1 SLC27A3	2.12e-04	515	120	11	GO:0015711
GeneOntologyBiologicalProcess	monocarboxylic acid transport	SLCO2B1 SLCO1B3 CPT1B SLCO1B1 SLC26A7 SLCO2A1 SLC27A3	2.52e-04	213	120	7	GO:0015718
Domain	OA_transporter	SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	7.69e-09	12	120	5	IPR004156
Domain	OATP	SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	7.69e-09	12	120	5	PF03137
Domain	KAZAL_2	SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	1.69e-05	50	120	5	PS51465
Domain	Kazal_dom	SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	1.87e-05	51	120	5	IPR002350
Domain	GREB1	GREB1L GREB1	4.09e-05	2	120	2	PF15782
Domain	GREB1	GREB1L GREB1	4.09e-05	2	120	2	IPR028422
Domain	Arginase	ARG1 ARG2	4.09e-05	2	120	2	IPR014033
Domain	Kazal_2	SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	8.14e-05	36	120	4	PF07648
Domain	GPS	PKD1L1 ADGRB3 PKDREJ ADGRG4	9.09e-05	37	120	4	IPR000203
Domain	Ureohydrolase_domain	ARG1 ARG2	1.22e-04	3	120	2	IPR023696
Domain	Ureohydrolase	ARG1 ARG2	1.22e-04	3	120	2	IPR006035
Domain	Ureohydrolase_Mn_BS	ARG1 ARG2	1.22e-04	3	120	2	IPR020855
Domain	-	ARG1 ARG2	1.22e-04	3	120	2	3.40.800.10
Domain	ARGINASE_2	ARG1 ARG2	1.22e-04	3	120	2	PS51409
Domain	ARGINASE_1	ARG1 ARG2	1.22e-04	3	120	2	PS01053
Domain	Arginase	ARG1 ARG2	1.22e-04	3	120	2	PF00491
Domain	KAZAL	SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	2.15e-04	46	120	4	SM00280
Domain	REJ	PKD1L1 PKDREJ	2.44e-04	4	120	2	PS51111
Domain	REJ_dom	PKD1L1 PKDREJ	2.44e-04	4	120	2	IPR014010
Domain	FA58C	CNTNAP5 CNTNAP4 DCBLD2	3.16e-04	21	120	3	SM00231
Domain	FA58C_3	CNTNAP5 CNTNAP4 DCBLD2	3.16e-04	21	120	3	PS50022
Domain	FA58C_1	CNTNAP5 CNTNAP4 DCBLD2	3.16e-04	21	120	3	PS01285
Domain	FA58C_2	CNTNAP5 CNTNAP4 DCBLD2	3.16e-04	21	120	3	PS01286
Domain	-	PTX4 ADGRG4 CNTNAP5 SLIT3 CNTNAP4	3.68e-04	95	120	5	2.60.120.200
Domain	CUB	ADGRB3 CSMD2 DCBLD2 MASP2	3.72e-04	53	120	4	PS01180
Domain	F5_F8_type_C	CNTNAP5 CNTNAP4 DCBLD2	4.74e-04	24	120	3	PF00754
Domain	FA58C	CNTNAP5 CNTNAP4 DCBLD2	4.74e-04	24	120	3	IPR000421
Domain	CUB_dom	ADGRB3 CSMD2 DCBLD2 MASP2	4.92e-04	57	120	4	IPR000859
Domain	Cadherin_C	CDH22 CDH2 CDH4	5.37e-04	25	120	3	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH22 CDH2 CDH4	5.37e-04	25	120	3	IPR000233
Domain	PKD/REJ-like	PKD1L1 PKDREJ	6.04e-04	6	120	2	IPR002859
Domain	REJ	PKD1L1 PKDREJ	6.04e-04	6	120	2	PF02010
Domain	Catenin_binding_dom	CDH22 CDH2 CDH4	8.37e-04	29	120	3	IPR027397
Domain	-	CDH22 CDH2 CDH4	8.37e-04	29	120	3	4.10.900.10
Domain	Cadherin_pro	CDH2 CDH4	8.42e-04	7	120	2	PF08758
Domain	TIG	PLXNB2 CAMTA1 PLXNA2	1.02e-03	31	120	3	PF01833
Domain	Cadherin_pro	CDH2 CDH4	1.12e-03	8	120	2	SM01055
Domain	Cadherin_pro_dom	CDH2 CDH4	1.12e-03	8	120	2	IPR014868
Domain	IPT	PLXNB2 CAMTA1 PLXNA2	1.12e-03	32	120	3	IPR002909
Domain	EGF-like_dom	LAMB2 CD93 CNTNAP5 HMCN2 SLIT3 CNTNAP4 MASP2	1.14e-03	249	120	7	IPR000742
Domain	GPS	ADGRB3 PKDREJ ADGRG4	1.34e-03	34	120	3	SM00303
Domain	Plexin_cytopl	PLXNB2 PLXNA2	1.43e-03	9	120	2	PF08337
Domain	PENTAXIN	PTX4 ADGRG4	1.43e-03	9	120	2	PS00289
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNB2 PLXNA2	1.43e-03	9	120	2	IPR013548
Domain	Plexin	PLXNB2 PLXNA2	1.43e-03	9	120	2	IPR031148
Domain	GPS	PKD1L1 ADGRB3 ADGRG4	1.58e-03	36	120	3	PS50221
Domain	EGF_2	LAMB2 CD93 CNTNAP5 HMCN2 SLIT3 CNTNAP4 MASP2	1.63e-03	265	120	7	PS01186
Domain	MFS_dom	SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	1.74e-03	134	120	5	IPR020846
Domain	PTX	PTX4 ADGRG4	1.78e-03	10	120	2	SM00159
Domain	LAM_G_DOMAIN	CNTNAP5 SLIT3 CNTNAP4	1.85e-03	38	120	3	PS50025
Domain	UQ_con	BIRC6 UBE2E1 UBE2S	2.00e-03	39	120	3	PF00179
Domain	Laminin_G_2	CNTNAP5 SLIT3 CNTNAP4	2.15e-03	40	120	3	PF02210
Domain	UBIQUITIN_CONJUGAT_1	BIRC6 UBE2E1 UBE2S	2.15e-03	40	120	3	PS00183
Domain	Pentaxin-related	PTX4 ADGRG4	2.17e-03	11	120	2	IPR001759
Domain	Pentaxin	PTX4 ADGRG4	2.17e-03	11	120	2	PF00354
Domain	PKD_channel	PKD1L1 PKDREJ	2.17e-03	11	120	2	PF08016
Domain	PKD1_2_channel	PKD1L1 PKDREJ	2.17e-03	11	120	2	IPR013122
Domain	UBIQUITIN_CONJUGAT_2	BIRC6 UBE2E1 UBE2S	2.31e-03	41	120	3	PS50127
Domain	UBQ-conjugat_E2	BIRC6 UBE2E1 UBE2S	2.31e-03	41	120	3	IPR000608
Domain	UBX	FAF1 UBXN11	2.59e-03	12	120	2	SM00166
Domain	LamG	CNTNAP5 SLIT3 CNTNAP4	2.83e-03	44	120	3	SM00282
Domain	ConA-like_dom	PTX4 MDGA2 ADGRG4 CNTNAP5 SLIT3 CNTNAP4	2.93e-03	219	120	6	IPR013320
Domain	UBX_dom	FAF1 UBXN11	3.05e-03	13	120	2	IPR001012
Domain	UBX	FAF1 UBXN11	3.05e-03	13	120	2	PF00789
Domain	UBX	FAF1 UBXN11	3.05e-03	13	120	2	PS50033
Domain	Galactose-bd-like	LAMB2 CNTNAP5 CNTNAP4 DCBLD2	3.17e-03	94	120	4	IPR008979
Domain	EGF_Ca-bd_CS	CD93 HMCN2 SLIT3 MASP2	3.55e-03	97	120	4	IPR018097
Domain	EGF_CA	CD93 HMCN2 SLIT3 MASP2	3.82e-03	99	120	4	PS01187
Domain	CUB	CSMD2 DCBLD2 MASP2	3.84e-03	49	120	3	PF00431
Domain	CUB	CSMD2 DCBLD2 MASP2	4.07e-03	50	120	3	SM00042
Domain	EGF	LAMB2 CD93 CNTNAP5 SLIT3 CNTNAP4 MASP2	4.13e-03	235	120	6	SM00181
Domain	IGc2	MDGA2 FCRL1 HMCN2 FGFR3 SDK1 LILRB5	4.13e-03	235	120	6	SM00408
Domain	EGF_3	CD93 CNTNAP5 HMCN2 SLIT3 CNTNAP4 MASP2	4.13e-03	235	120	6	PS50026
Domain	Ig_sub2	MDGA2 FCRL1 HMCN2 FGFR3 SDK1 LILRB5	4.13e-03	235	120	6	IPR003598
Domain	-	BIRC6 UBE2E1 UBE2S	4.30e-03	51	120	3	3.10.110.10
Domain	-	CSMD2 DCBLD2 MASP2	4.55e-03	52	120	3	2.60.120.290
Domain	UBQ-conjugating_enzyme/RWD	BIRC6 UBE2E1 UBE2S	4.80e-03	53	120	3	IPR016135
Domain	Quinoprotein_ADH-like_supfam	FAM234B DMXL2 CFAP251	4.80e-03	53	120	3	IPR011047
Domain	EGF-type_Asp/Asn_hydroxyl_site	CD93 HMCN2 SLIT3 MASP2	4.87e-03	106	120	4	IPR000152
Domain	MFS	SLCO1B3 SLCO1B1 SLCO5A1 SLCO2A1	5.20e-03	108	120	4	PS50850
Domain	LH2	PKD1L1 PKDREJ	5.86e-03	18	120	2	SM00308
Domain	EGF_1	LAMB2 CNTNAP5 HMCN2 SLIT3 CNTNAP4 MASP2	6.12e-03	255	120	6	PS00022
Domain	Laminin_G	CNTNAP5 SLIT3 CNTNAP4	6.17e-03	58	120	3	IPR001791
Pathway	REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	4.95e-07	11	90	4	M930
Pathway	REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	7.39e-07	12	90	4	MM15476
Pathway	WP_SULFATASE_AND_AROMATASE_PATHWAY	SLCO2B1 ESR2 SLCO1B3 SLCO1B1	1.48e-06	14	90	4	M48085
Pathway	REACTOME_ATORVASTATIN_ADME	SLCO2B1 SLCO1B3 SLCO1B1	2.06e-05	9	90	3	M45020
Pathway	REACTOME_HEME_DEGRADATION	SLCO2B1 SLCO1B3 SLCO1B1	1.08e-04	15	90	3	M27060
Pathway	REACTOME_ATORVASTATIN_ADME	SLCO2B1 SLCO1B3 SLCO1B1	1.08e-04	15	90	3	MM15697
Pathway	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	1.31e-04	41	90	4	MM15075
Pathway	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	1.58e-04	43	90	4	M881
Pathway	REACTOME_HEME_DEGRADATION	SLCO2B1 SLCO1B3 SLCO1B1	2.65e-04	20	90	3	MM14721
Pubmed	SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.	SLCO2B1 SLCO1B3 SLCO1B1	4.32e-08	3	123	3	24762081
Pubmed	Impact of regulatory polymorphisms in organic anion transporter genes in the human liver.	SLCO2B1 SLCO1B3 SLCO1B1	4.32e-08	3	123	3	19620935
Pubmed	Comparison of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes among five ethnic groups.	SLCO2B1 SLCO1B3 SLCO1B1	4.32e-08	3	123	3	26409184
Pubmed	Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats.	SLCO2B1 SLCO1B3 SLCO1B1	4.32e-08	3	123	3	28013215
Pubmed	Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1/1B3 and 2B1.	SLCO2B1 SLCO1B3 SLCO1B1	4.32e-08	3	123	3	29422623
Pubmed	Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.	SLCO2B1 SLCO1B3 SLCO1B1	4.32e-08	3	123	3	26383540
Pubmed	Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens.	SLCO2B1 SLCO1B3 SLCO1B1	4.32e-08	3	123	3	32587096
Pubmed	Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties.	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	4.82e-08	11	123	4	14579113
Pubmed	Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cells.	SLCO2B1 SLCO1B3 SLCO1B1	1.72e-07	4	123	3	21849517
Pubmed	Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.	SLCO2B1 SLCO1B3 SLCO1B1	1.72e-07	4	123	3	17906856
Pubmed	Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier.	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	2.62e-07	16	123	4	35307651
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A PNPLA2 SHC1 LAMB2 LRRK1 RALGAPA2 PLXNB2 FAAP100 BIRC6 CIC TFE3 GET4 ZBED4 SH3TC1 PAX2 CRAMP1 TRAPPC9	3.81e-07	1105	123	17	35748872
Pubmed	Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.	SLCO2B1 SLCO1B3 SLCO1B1	4.29e-07	5	123	3	20635135
Pubmed	Mutations in GREB1L Cause Bilateral Kidney Agenesis in Humans and Mice.	GREB1L PAX2 GREB1	8.57e-07	6	123	3	29100091
Pubmed	Genetic dissection of cadherin function during nephrogenesis.	PAX2 CDH2 CDH4	1.50e-06	7	123	3	11839813
Pubmed	Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters.	SLCO2B1 SLCO1B3 SLCO1B1	2.39e-06	8	123	3	19129463
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	SOX6 ADGRB3 DAO CSMD2 YES1 SH3TC1 SLIT3 GREB1	4.94e-06	265	123	8	19240061
Pubmed	Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).	PLBD1 CSMD2 CNTNAP4 TRAPPC9	1.00e-05	38	123	4	22952603
Pubmed	Identification of arginase in human placental villi.	ARG1 ARG2	1.24e-05	2	123	2	16720041
Pubmed	Molecular cloning of mouse pancreatic islet R-cadherin: differential expression in endocrine and exocrine tissue.	CDH2 CDH4	1.24e-05	2	123	2	8247017
Pubmed	Cloning and characterization of the mouse and rat type II arginase genes.	ARG1 ARG2	1.24e-05	2	123	2	9608538
Pubmed	Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia.	ARG1 ARG2	1.24e-05	2	123	2	17997338
Pubmed	Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase.	ARG1 ARG2	1.24e-05	2	123	2	19801451
Pubmed	Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.	ARG1 ARG2	1.24e-05	2	123	2	16794538
Pubmed	Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	29944058
Pubmed	SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	36964102
Pubmed	SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.	SLCO2B1 SLCO1B3	1.24e-05	2	123	2	37856781
Pubmed	Deficient arginase II expression without alteration in arginase I expression attenuated experimental autoimmune encephalomyelitis in mice.	ARG1 ARG2	1.24e-05	2	123	2	29574762
Pubmed	Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1.	SLCO2B1 SLCO2A1	1.24e-05	2	123	2	31467884
Pubmed	Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	23340295
Pubmed	Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	29777022
Pubmed	Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	26191226
Pubmed	Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	24194513
Pubmed	Polyamine homeostasis in arginase knockout mice.	ARG1 ARG2	1.24e-05	2	123	2	17686999
Pubmed	Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.	ARG1 ARG2	1.24e-05	2	123	2	25205225
Pubmed	Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	24855184
Pubmed	Defective arginine metabolism impairs mitochondrial homeostasis in Caenorhabditiselegans.	ARG1 ARG2	1.24e-05	2	123	2	32305173
Pubmed	Differential Associations of SLCO Transporters with Prostate Cancer Aggressiveness between African Americans and European Americans.	SLCO5A1 SLCO2A1	1.24e-05	2	123	2	33619025
Pubmed	Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	26474710
Pubmed	Effects of anthocyans on the expression of organic anion transporting polypeptides (SLCOs/OATPs) in primary human hepatocytes.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	25578040
Pubmed	Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations.	GREB1L GREB1	1.24e-05	2	123	2	29100090
Pubmed	Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.	ARG1 ARG2	1.24e-05	2	123	2	25375125
Pubmed	Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	24989890
Pubmed	Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung.	ARG1 ARG2	1.24e-05	2	123	2	12679322
Pubmed	Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	21719246
Pubmed	Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	20877131
Pubmed	Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect.	ARG1 ARG2	1.24e-05	2	123	2	15128819
Pubmed	Ornithine deficiency in the arginase double knockout mouse.	ARG1 ARG2	1.24e-05	2	123	2	16753325
Pubmed	Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	16534140
Pubmed	Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	18321482
Pubmed	A Gene Implicated in Activation of Retinoic Acid Receptor Targets Is a Novel Renal Agenesis Gene in Humans.	GREB1L GREB1	1.24e-05	2	123	2	28739660
Pubmed	Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	18314419
Pubmed	Distinct roles of arginases 1 and 2 in diabetic nephropathy.	ARG1 ARG2	1.24e-05	2	123	2	28446459
Pubmed	OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	21691816
Pubmed	FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.	FBXO7 RBFOX2	1.24e-05	2	123	2	37822160
Pubmed	Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis.	ARG1 ARG2	1.24e-05	2	123	2	12813022
Pubmed	Linking organic anion transporting polypeptide 1B1 and 1B3 (OATP1B1 and OATP1B3) interaction profiles to hepatotoxicity - The hyperbilirubinemia use case.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	28063966
Pubmed	Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response.	ARG1 ARG2	1.24e-05	2	123	2	20124949
Pubmed	Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas.	SLCO2B1 SLCO1B3	1.24e-05	2	123	2	28493059
Pubmed	Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	22240838
Pubmed	The human arginases and arginase deficiency.	ARG1 ARG2	1.24e-05	2	123	2	9686347
Pubmed	Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	17412826
Pubmed	Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3.	SLCO2B1 SLCO2A1	1.24e-05	2	123	2	26692285
Pubmed	Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.	SLCO2B1 SLCO1B3	1.24e-05	2	123	2	21266523
Pubmed	Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability.	ARG1 ARG2	1.24e-05	2	123	2	33410970
Pubmed	Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis.	SLCO2B1 SLCO1B1	1.24e-05	2	123	2	12130747
Pubmed	Diabetes-induced vascular dysfunction involves arginase I.	ARG1 ARG2	1.24e-05	2	123	2	22058149
Pubmed	Arginase isoenzymes in human cirrhotic liver.	ARG1 ARG2	1.24e-05	2	123	2	19636440
Pubmed	Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	22771883
Pubmed	Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia.	ARG1 ARG2	1.24e-05	2	123	2	19684035
Pubmed	Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	18180273
Pubmed	Structure of human drug transporters OATP1B1 and OATP1B3.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	37723174
Pubmed	Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective.	ARG1 ARG2	1.24e-05	2	123	2	32722521
Pubmed	Resting skeletal muscle PNPLA2 (ATGL) and CPT1B are associated with peak fat oxidation rates in men and women but do not explain observed sex differences.	PNPLA2 CPT1B	1.24e-05	2	123	2	33675111
Pubmed	In focus in HCB.	SLCO2B1 SLCO1B3	1.24e-05	2	123	2	28815335
Pubmed	Effects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	23670789
Pubmed	Functional cis-heterodimers of N- and R-cadherins.	CDH2 CDH4	1.24e-05	2	123	2	10662782
Pubmed	SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.	SLCO2B1 SLCO1B3	1.24e-05	2	123	2	21606417
Pubmed	Recent advances in arginine metabolism: roles and regulation of the arginases.	ARG1 ARG2	1.24e-05	2	123	2	19508396
Pubmed	Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	17496208
Pubmed	Rotor Syndrome	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	23236639
Pubmed	Arginase expression in mouse embryonic development.	ARG1 ARG2	1.24e-05	2	123	2	12049781
Pubmed	A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma.	CIC FOXO4	1.24e-05	2	123	2	25007147
Pubmed	Roles of arginase variants, atopy, and ozone in childhood asthma.	ARG1 ARG2	1.24e-05	2	123	2	19281908
Pubmed	Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	27098745
Pubmed	Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	24740327
Pubmed	Arginase enzymes in the human prostate: A molecular biological and immunohistochemical approach.	ARG1 ARG2	1.24e-05	2	123	2	31482616
Pubmed	Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia.	ARG1 ARG2	1.24e-05	2	123	2	33676021
Pubmed	UGT-dependent regioselective glucuronidation of ursodeoxycholic acid and obeticholic acid and selective transport of the consequent acyl glucuronides by OATP1B1 and 1B3.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	31299240
Pubmed	Genetic polymorphisms in arginase I and II and childhood asthma and atopy.	ARG1 ARG2	1.24e-05	2	123	2	16387594
Pubmed	In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	23886114
Pubmed	OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture.	SLCO1B3 SLCO1B1	1.24e-05	2	123	2	21787759
Pubmed	Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction.	ARG1 ARG2	1.24e-05	2	123	2	26537638
Pubmed	Single Nucleotide Polymorphisms in the Arginase 1 and 2 Genes Are Differentially Associated with Circulating l-Arginine Concentration in Unsupplemented and l-Arginine-Supplemented Adults.	ARG1 ARG2	1.24e-05	2	123	2	33232463
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	CNTNAP4 CDH2 CDH4 SDK1 PLXNA2	1.86e-05	91	123	5	28558017
Pubmed	Overexpression of Pax6 results in microphthalmia, retinal dysplasia and defective retinal ganglion cell axon guidance.	PAX2 CDH2 CDH4	1.90e-05	15	123	3	18507827
Pubmed	Loss of Foxc1 and Foxc2 function in chondroprogenitor cells disrupts endochondral ossification.	SOX6 FGFR3 FOXC1	2.83e-05	17	123	3	34331943
Pubmed	Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.	SLCO1B3 SLCO1B1	3.71e-05	3	123	2	31047942
Pubmed	Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.	SLCO1B3 SLCO1B1	3.71e-05	3	123	2	26146841
Pubmed	Arginase in glomerulonephritis.	ARG1 ARG2	3.71e-05	3	123	2	11849441
Interaction	SLCO1B3 interactions	FNDC3B SLCO1B3 SLCO1B1 BRCA2	2.52e-07	10	121	4	int:SLCO1B3
Interaction	GAA interactions	ESR2 FKBP9 SIAE MTHFD1 SPRTN CDH2 DCBLD2 GAA	1.57e-06	135	121	8	int:GAA
Interaction	SIAE interactions	FKBP9 LAMB2 PLXNB2 SIAE DCBLD2 GAA	1.07e-05	83	121	6	int:SIAE
Interaction	PTPRK interactions	ESR2 LAMB2 PLXNB2 SIAE SPRTN CDH2 DCBLD2 PLXNA2	1.17e-05	177	121	8	int:PTPRK
Cytoband	22q13.33	CPT1B PLXNB2 ZBED4 MOV10L1	3.37e-06	38	123	4	22q13.33
GeneFamily	Solute carriers	SLC25A24 SLCO2B1 SLCO1B3 SLCO1B1 SLCO5A1 SLC44A5 SLC26A7 SLCO2A1 SLC27A3	4.05e-05	395	76	9	752
GeneFamily	CD molecules\|Type I classical cadherins	CDH2 CDH4	1.73e-04	5	76	2	1185
GeneFamily	Plexins	PLXNB2 PLXNA2	6.16e-04	9	76	2	683
GeneFamily	Ubiquitin conjugating enzymes E2	BIRC6 UBE2E1 UBE2S	6.78e-04	41	76	3	102
GeneFamily	UPF1 like RNA helicases	ZNFX1 MOV10L1	9.36e-04	11	76	2	1169
GeneFamily	UBX domain containing	FAF1 UBXN11	1.32e-03	13	76	2	364
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MDGA2 HMCN2 FGFR3 SDK1	4.73e-03	161	76	4	593
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN	PLBD1 DMXL2 PLXNB2 TFE3 CD93 SH3TC1 GCA SLC27A3	4.86e-06	200	123	8	M4496
Coexpression	GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN	CFAP251 MPEG1 CD93 CDH2 SDK1 PLXNA2 RBFOX2	1.23e-05	163	123	7	M6722
Coexpression	HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN	PLBD1 DMXL2 FGD2 MPEG1 LRRK1 PLXNB2 SLCO5A1 GCA	3.07e-05	258	123	8	M41144
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	SHC1 PLXNB2 FAF1 SGPL1 CCSER2 UTP3 FERMT2 CDH2 CWF19L1 PLXNA2 RBFOX2	3.46e-05	519	123	11	M3395
Coexpression	GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN	PLBD1 DMXL2 PLXNB2 CD93 SH3TC1 GCA SLC27A3	4.56e-05	200	123	7	M4480
Coexpression	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN	DMXL2 PLXNB2 CD93 EIF4EBP1 GCA GAA SLC27A3	4.56e-05	200	123	7	M3088
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	SHC1 PLXNB2 FAF1 SGPL1 CCSER2 UTP3 FERMT2 CDH2 CWF19L1 PLXNA2 RBFOX2	5.20e-05	543	123	11	MM997
Coexpression	NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	PLXNB2 ZBED4 MOV10L1	6.54e-05	17	123	3	M12053
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_DN	DAO SLCO1B3 SYNPO PLXNB2 SLCO1B1 PEBP1 SGPL1	6.79e-05	213	123	7	M12176
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-3	PLBD1 FGD2 MPEG1 LRRK1 YES1 PLXNB2 ARG2 SLCO5A1 CCSER2 GCA CDH2 SLC27A3	5.34e-06	418	122	12	GSM854291_500
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_1000	ARHGEF12 LAMB2 WLS SLCO2A1 CCSER2 FERMT2 FOXC1	8.78e-06	127	122	7	gudmap_kidney_adult_Mesangium_Meis_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	SOX6 ADGRB3 MDGA2 YES1 SLCO5A1 SIAE FGFR3 UTP3 CDH2 CDH4	8.80e-06	298	122	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5	SLCO2B1 FKBP9 ARHGEF12 LAMB2 YES1 PLXNB2 CD93 FAM171A1 PIEZO2 SLCO2A1 FERMT2 PLXNA2	1.28e-05	456	122	12	GSM777032_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	SOX6 FGD2 ADGRB3 MDGA2 RALGAPA2 YES1 SLCO5A1 SIAE BRCA2 SLC26A7 SLIT3 PAX2 FGFR3 UTP3 SPRTN CDH2 CDH4	4.90e-05	986	122	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	FNDC3B SLCO2B1 FKBP9 ARHGEF12 LAMB2 PIEZO2 SLCO2A1 SLIT3 FERMT2 DCBLD2 RBFOX2	6.18e-05	453	122	11	GSM777067_500
CoexpressionAtlas	Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4	SLCO2B1 FKBP9 ARHGEF12 LAMB2 YES1 PLXNB2 CD93 PIEZO2 SLCO2A1 FERMT2 PLXNA2	6.95e-05	459	122	11	GSM777037_500
CoexpressionAtlas	Myeloid Cells, DC.IIhilang+103+11blo.SLN, MHCIIhi CD11c+ Langerin+ CD103+ CD11b-, Lymph Node, avg-3	MPEG1 ZNF318 LRRK1 YES1 ARG2 SLCO5A1 CCSER2 GCA CDH2 SLC27A3	9.21e-05	393	122	10	GSM538268_500
CoexpressionAtlas	kidney_adult_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	FNDC3B ARHGEF12 LAMB2 WLS SLCO2A1 CCSER2 FERMT2	1.20e-04	191	122	7	gudmap_kidney_adult_Podocyte_MafB_k1_1000
CoexpressionAtlas	facebase_RNAseq_e9.5_OlfPlac_2500_K3	SOX6 FAM234B FGD2 NOL6 FAF1 ARG2 GREB1L UBE2E1 ZBED4 BRCA2 GLIS2 SLIT3 GCA UBE2S GREB1 CDH2 SLC27A3 MASP2	1.49e-04	1187	122	18	facebase_RNAseq_e9.5_OlfPlac_2500_K3
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 DMXL2 FGD2 MPEG1 PLXNB2 UBXN11 SH3TC1 GAA	7.54e-08	196	123	8	89ff93cbfbe39fbdf2498e8fdc5d61a0ecb26fc9
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 DMXL2 FGD2 MPEG1 PLXNB2 UBXN11 SH3TC1 GAA	7.54e-08	196	123	8	09574bfeb1d3da53b5471cfb0602946d328b3b5c
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FNDC3B FKBP9 ARHGEF12 WLS AZIN1 FERMT2 GAA FOXC1	7.85e-08	197	123	8	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC3B FKBP9 ARHGEF12 WLS AZIN1 FERMT2 GAA FOXC1	7.85e-08	197	123	8	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	control-Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLBD1 DMXL2 MPEG1 WLS PLXNB2 CD93 GCA GAA	8.81e-08	200	123	8	251ca08fab5cc2a4e280db6a6286a9ebaef3e61a
ToppCell	control-HLA-DR-_S100A+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLBD1 DMXL2 MPEG1 WLS PLXNB2 CD93 GCA GAA	8.81e-08	200	123	8	9e3e13a68bc1110fa000ec2d80f4c654ddbce17e
ToppCell	facs-Skin-Telogen-3m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX6 FAM234B PLBD1 WLS SLCO2A1 CDH4 SLC27A3	9.39e-07	188	123	7	8cc927b4c51d982fdafa04dc7393617ad9bb220e
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 DMXL2 MPEG1 PLXNB2 UBXN11 GCA GAA	1.12e-06	193	123	7	1db487e5f81849740d57cc3e2b5739e8f7581efb
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FGD2 MPEG1 LRRK1 SLCO5A1 BRCA2 SH3TC1 GCA	1.16e-06	194	123	7	5a048bd2af30975fdc57ff40bc49aa5811c830d8
ToppCell	BLOOD--(3)_Classical_Mono-1\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PLBD1 DMXL2 MPEG1 WLS CD93 EIF4EBP1 GCA	1.20e-06	195	123	7	4702d234731d4cd47d5fba570e439deee21c67f9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 SYNPO RALGAPA2 YES1 CD93 SLCO2A1 PLXNA2	1.20e-06	195	123	7	818bc18c5834238e5f733cac6fe928ed0788f57d
ToppCell	VE-granulo1-\|VE / Condition, Cell_class and T cell subcluster	PLBD1 DMXL2 FGD2 MPEG1 PLXNB2 CD93 GCA	1.24e-06	196	123	7	ab3f2ce294c7e503d86254a195be0cf500a2c5e4
ToppCell	VE-granulo1\|VE / Condition, Cell_class and T cell subcluster	PLBD1 DMXL2 FGD2 MPEG1 PLXNB2 CD93 GCA	1.24e-06	196	123	7	6dbd3acb30173d7f0b7bca0a82f435f00ca85835
ToppCell	control-Classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 EIF4EBP1 GCA	1.28e-06	197	123	7	881d173f6c69efc426679832d917c639d9394098
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DMXL2 FGD2 SLCO2B1 MPEG1 SH3TC1 SGPL1 LILRB5	1.28e-06	197	123	7	10190b877bf46ba2163d203df9dd3b498c66e52f
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FKBP9 LAMB2 WLS GLIS2 SLIT3 FGFR3 CDH2	1.28e-06	197	123	7	2ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCell	(6)_Macrophage\|World / shred on Cell_type and subtype	PLBD1 DMXL2 SLCO2B1 MPEG1 WLS CD93 LILRB5	1.28e-06	197	123	7	010b275d4da4a896175ad7fbaa96d1dc11a0b744
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA GAA	1.28e-06	197	123	7	a1d42d0177630e08f36a96a6272f796244c1a319
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA GAA	1.28e-06	197	123	7	bb0d814d88a14199eb8ab2b3bd67511b19e3ab5d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 EIF4EBP1 GAA	1.28e-06	197	123	7	280804810041783f1b7704914b62ffefbb0d88f6
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 UBXN11 EIF4EBP1	1.33e-06	198	123	7	74591eba5dbb2d77d416309326a26be969e4ad42
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FKBP9 LAMB2 PIEZO2 HMCN2 SLIT3 FERMT2 RBFOX2	1.33e-06	198	123	7	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	BLOOD--(3)_MNP\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 EIF4EBP1 GCA	1.33e-06	198	123	7	4bba020c2bef7f4cc0c9237644f5a39398039286
ToppCell	Monocytes\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PLBD1 DMXL2 FGD2 SLCO2B1 MPEG1 PLXNB2 CD93	1.33e-06	198	123	7	8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 UBXN11 EIF4EBP1	1.33e-06	198	123	7	3e1e79bb7b13540a06956b59c6a62984efea19ee
ToppCell	Control-Myeloid\|Control / Disease group, lineage and cell class	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 EIF4EBP1 GCA	1.37e-06	199	123	7	5c9d29426f8b4cc813174378a3aefc18a1ae00cc
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 EIF4EBP1 GCA	1.37e-06	199	123	7	4fc03377c017209111561789226621d258291481
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DMXL2 FGD2 SLCO2B1 MPEG1 SH3TC1 SGPL1 LILRB5	1.37e-06	199	123	7	f34c15df58fbdc6c90e30800e26fabbf828ad10b
ToppCell	PBMC-Control-Myeloid\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 EIF4EBP1 GCA	1.37e-06	199	123	7	eaa7061db4e55fe6bf68cc356509e101c749d817
ToppCell	BAL-Control-cDC_0\|Control / Compartment, Disease Groups and Clusters	FNDC3B DMXL2 SLCO2B1 UBXN11 LILRB5 GAA SLC27A3	1.37e-06	199	123	7	4518ffa51ead9da1ddf07bf048b18602e50f0f84
ToppCell	PBMC-Control-Myeloid\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 EIF4EBP1 GCA	1.37e-06	199	123	7	afd57bed57e6bd63eb4e7cbbe36f75f15befc4e0
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DMXL2 FGD2 SLCO2B1 MPEG1 SH3TC1 SGPL1 LILRB5	1.37e-06	199	123	7	5ceeed92f831d068ff4bb3994f420002338330e7
ToppCell	BAL-Severe-cDC_0\|Severe / Compartment, Disease Groups and Clusters	PLBD1 DMXL2 SLCO2B1 RHBDD2 UBXN11 LILRB5 GAA	1.37e-06	199	123	7	d39be8b173156bf87baddd3caed4b35597c53ea1
ToppCell	Control-Control-Myeloid\|Control / Disease, condition lineage and cell class	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 EIF4EBP1 GCA	1.42e-06	200	123	7	dc9770e8e7e8fd46ce504d166a977d9707c14d42
ToppCell	COVID_vent-Myeloid\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA GAA	1.42e-06	200	123	7	621af09aae34226902c03edf556562f3ab35a7d8
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DMXL2 FGD2 SLCO2B1 MPEG1 SH3TC1 LILRB5 GAA	1.42e-06	200	123	7	1a080564de59abd59d3208a73441b6346e1c7cd8
ToppCell	healthy_donor-Myeloid-Monocytic-CD14+_Monocyte\|healthy_donor / Disease condition, Lineage, Cell class and subclass	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA GAA	1.42e-06	200	123	7	e4f4ac674f3e085f52c6affeb6aeadaec7fffa73
ToppCell	control-HLA-DR-_S100A+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLBD1 MPEG1 WLS PLXNB2 CD93 GCA GAA	1.42e-06	200	123	7	107a0665fb20247511a430178effd7630a619488
ToppCell	COVID_vent-Myeloid-Monocytic-CD14+_Monocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA GAA	1.42e-06	200	123	7	e57452b73abb21cb3f645d45523ab93f6bef0243
ToppCell	control-Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLBD1 DMXL2 MPEG1 WLS CD93 GCA GAA	1.42e-06	200	123	7	b5d197472799cc61d7497faed91ac2564ae4930a
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKDREJ GREB1L MOV10L1 DENND2C PLXNA2 MASP2	5.16e-06	158	123	6	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKDREJ GREB1L MOV10L1 DENND2C PLXNA2 MASP2	5.16e-06	158	123	6	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ESR2 CSMD2 GREB1L FAM171A1 CCSER2 LILRB5	5.96e-06	162	123	6	19395bdb282b4a2d88cd33191af12c24a88c3d16
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	MDGA2 GREB1L CNTNAP5 PIEZO2 CNTNAP4 CDH4	6.17e-06	163	123	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SOX6 SLC44A5 SLIT3 PAX2 CDH2 SDK1	7.34e-06	168	123	6	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	DMXL2 FGD2 SLCO2B1 SLCO5A1 GET4 CDH2	7.85e-06	170	123	6	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR2 SLC44A5 SLIT3 CDH2 CDH4 FOXC1	9.89e-06	177	123	6	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SOX6 MDGA2 SLIT3 PAX2 CDH2 SDK1	1.02e-05	178	123	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	frontal_cortex-Non-neuronal\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLCO2B1 LAMB2 LRRK1 AQP4 FGFR3 FOXC1	1.05e-05	179	123	6	ef01478bd03eb00f0ff2b6a8ae9244687c5f85aa
ToppCell	facs-Skin-Anagen-3m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX6 PLBD1 WLS MTHFD1 SLCO2A1 CDH4	1.16e-05	182	123	6	22d6f4790950508e8aa27e02a8133af5f53f13c8
ToppCell	3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1\|GI_small-bowel / Manually curated celltypes from each tissue	FGD2 MPEG1 SLCO5A1 CD93 CDH2 SDK1	1.23e-05	184	123	6	8e393eea7240584a3cef718bee094e2705ec1891
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAO AQP4 GREB1L FGFR3 GREB1 CDH4	1.23e-05	184	123	6	f6148e9591e8845cc62668e49fd52755257cdc7e
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ESR2 CACHD1 RALGAPA2 CD93 FAM171A1 SLCO2A1	1.27e-05	185	123	6	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 DMXL2 MPEG1 CD93 FAM157C GCA	1.31e-05	186	123	6	05c40bac5c0ade8b67b7c2112739466e02dbf22b
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YES1 CD93 FAM171A1 PIEZO2 SH3TC1 SLCO2A1	1.39e-05	188	123	6	524d1d928c9386acf20e53d31894107dd7290dc7
ToppCell	normal_Lymph_Node-Myeloid_cells-mo-Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	DMXL2 SLCO2B1 FKBP9 MPEG1 CD93 LILRB5	1.39e-05	188	123	6	e83de94a9b47a6a90e98face887eae031a322af6
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YES1 CD93 FAM171A1 PIEZO2 SH3TC1 SLCO2A1	1.39e-05	188	123	6	1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YES1 CD93 FAM171A1 PIEZO2 SH3TC1 SLCO2A1	1.39e-05	188	123	6	cd2d1f8e43c252dd8730a5758458ef63e7ffc836
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YES1 CD93 FAM171A1 PIEZO2 SH3TC1 SLCO2A1	1.39e-05	188	123	6	f5a2f324f3f6c5078d57130392d3f1ba74f29094
ToppCell	5'-Airway_Nasal-Endothelial\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YES1 CD93 FAM171A1 PIEZO2 SH3TC1 SLCO2A1	1.39e-05	188	123	6	6c9d5e4014f807149328ff4eabd5e86dfe18094d
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CACHD1 WLS SLCO2A1 SLIT3 PAX2 SDK1	1.39e-05	188	123	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	facs-Skin-nan-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX6 PLBD1 DAO WLS SLCO2A1 CDH4	1.43e-05	189	123	6	6c71e81373cb7822de23c193a6350b6df9f567bc
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO YES1 CD93 SLCO2A1 PLXNA2 FOXC1	1.43e-05	189	123	6	d9c2adbbe3e40eb8d57200b6411533e6685ea0d2
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO YES1 CD93 SLCO2A1 PLXNA2 FOXC1	1.43e-05	189	123	6	476226787c8ea0c9834a6f4c99ac7091cc20a455
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO YES1 CD93 SLCO2A1 PLXNA2 FOXC1	1.43e-05	189	123	6	3fe69bad6427e41b8d2dae450828cc21e9c3b3ad
ToppCell	IPF-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	CACHD1 FAF1 ARG2 SH3TC1 FAM157A FGFR3	1.48e-05	190	123	6	4f15842b424eefadbfe451875e517cf70e29607f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC44A5 PEBP1 SLIT3 FGFR3 CDH2 FOXC1	1.48e-05	190	123	6	b855b8b7d3439023390ca44629c1a99f5d4c6801
ToppCell	severe_COVID-19-RBC\|severe_COVID-19 / disease group, cell group and cell class (v2)	SOX6 ARHGEF12 ARG1 FBXO7 FOXO4 CTSE	1.48e-05	190	123	6	3a5723c2daf58c1932edd70910db4b8b30f63f42
ToppCell	severe_COVID-19-RBC\|World / disease group, cell group and cell class (v2)	SOX6 ARHGEF12 ARG1 FBXO7 FOXO4 CTSE	1.57e-05	192	123	6	1b4e28fd2e3d70ab48dbe96b280d35395889fbe2
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTX4 SYNPO RALGAPA2 CD93 SLCO2A1 FOXC1	1.57e-05	192	123	6	14a816ef116aa992f86edab411f043cf7d07fe04
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX6 WLS CACNG8 CAMTA1 CDH2 DCBLD2	1.57e-05	192	123	6	1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7
ToppCell	facs-Heart-LA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTX4 SYNPO RALGAPA2 CD93 SLCO2A1 FOXC1	1.57e-05	192	123	6	847822514d747a21d5eb40e04ba9a023fd32bd65
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTX4 RALGAPA2 TEX35 SLCO2A1 CDH4 FOXC1	1.62e-05	193	123	6	d0a5f212f8e8a13dbbe3e41df92548ef82eef70b
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO1B3 RALGAPA2 YES1 CD93 FAM171A1 PIEZO2	1.62e-05	193	123	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	droplet-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PIEZO2 SLCO2A1 GLIS2 FGFR3 FERMT2 PLXNA2	1.62e-05	193	123	6	25129080f8a40b2988a5d9dfec36ff9e72c27e61
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA	1.62e-05	193	123	6	69352551ad5db325ac0d6df2ac1e35ae473ac01f
ToppCell	Control-Classical_Monocyte\|Control / Disease condition and Cell class	FNDC3B PLBD1 DMXL2 WLS CD93 GCA	1.66e-05	194	123	6	9e33e1b54b4114f9e6981819834bb796ed7192b5
ToppCell	(6)_Endothelial-B_(Artery)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	SYNPO CD93 FAM171A1 SLCO2A1 PLXNA2 FOXC1	1.66e-05	194	123	6	0cf4e67d4024652794b5bfdd4a71a7d98900b4c8
ToppCell	droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 SLCO2A1 GLIS2 FGFR3 FERMT2 PLXNA2	1.66e-05	194	123	6	f35f03412b596b6b570b377ba1a607409d984bb1
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGEF12 SLCO1B3 CACHD1 CD93 FAM171A1 RBFOX2	1.66e-05	194	123	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DMXL2 FGD2 SLCO2B1 CD93 SH3TC1 LILRB5	1.66e-05	194	123	6	663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 DMXL2 MPEG1 PLXNB2 UBXN11 GAA	1.66e-05	194	123	6	a94f9f7179a5733e3c378ff8b337e288785433a1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA	1.71e-05	195	123	6	9f7dc9328d244291baf92b03c346c2189b58e7c4
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRB3 CSMD2 ARG1 HMCN2 OTOGL GCA	1.71e-05	195	123	6	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLBD1 PNPLA2 DMXL2 MPEG1 ARG1 GCA	1.71e-05	195	123	6	b0dbaae86f5703ab62f925e0f36500274044884a
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA	1.71e-05	195	123	6	0110b976f98561ecd2e20ff6e7e3960a401bb7c2
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FGD2 MPEG1 PLXNB2 UBXN11 SH3TC1 GAA	1.71e-05	195	123	6	4e9513a7ea69fa9fc8e9ff2da8ef3f44e8fdc70d
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRB3 CSMD2 ARG1 HMCN2 OTOGL GCA	1.71e-05	195	123	6	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FGD2 MPEG1 PLXNB2 UBXN11 SH3TC1 GAA	1.71e-05	195	123	6	a25a342380e258b784227f7298f609ccaa1f9ce7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RALGAPA2 CD93 FAM171A1 CACNG8 HMCN2 PLXNA2	1.71e-05	195	123	6	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA	1.71e-05	195	123	6	050fc59b328391d6e3ce23051764a842dcbb3144
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Classical_Monocyte\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA	1.76e-05	196	123	6	76101d5ebe2a74c0a0a885ec31c3c1847bda8a7b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 SYNPO RALGAPA2 CD93 SLCO2A1 PLXNA2	1.76e-05	196	123	6	7cbb19108b4553ef60ef5c230a29de1662c02efe
ToppCell	10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages\|GI_small-bowel / Manually curated celltypes from each tissue	DMXL2 FGD2 SLCO2B1 MPEG1 CD93 LILRB5	1.76e-05	196	123	6	075e5746fa5cb121115a1d51b823c0fbf8d54305
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 SYNPO RALGAPA2 CD93 SLCO2A1 PLXNA2	1.76e-05	196	123	6	4cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 SYNPO RALGAPA2 CD93 SLCO2A1 PLXNA2	1.76e-05	196	123	6	d37f714d4fb57e958f3738fdda085560813e5bb5
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA	1.76e-05	196	123	6	b6cadb2098b0997d205903beb8a6992c5f692642
ToppCell	(0)_Myeloid-(000)_CD14+_Monocyte\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	PLBD1 DMXL2 MPEG1 CD93 UBXN11 GCA	1.76e-05	196	123	6	e9718642ee2751c9d46a1b968547bdcb59cdfd30
ToppCell	(000)_CD14+_Monocyte\|World / immune cells in Peripheral Blood (logTPM normalization)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA	1.81e-05	197	123	6	cff498bc7b153f28dd013eaeb73ead4fb62fb44c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLBD1 DMXL2 MPEG1 PLXNB2 CD93 GCA	1.81e-05	197	123	6	2afc23f7394d9b40bdf06527c5e6b553e1b02dca
Drug	guanidinosuccinic acid	SLCO1B1 PKDREJ ARG1 ARG2 GAA	1.27e-07	23	122	5	CID000097856
Drug	2-ketoarginine	DAO ARG1 ARG2 GAA	3.76e-07	12	122	4	CID000000558
Drug	Dihydromicrocystin Lr	SLCO2B1 SLCO1B3 SLCO1B1	5.98e-07	4	122	3	CID006441227
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; HL60; HT_HG-U133A	FAM234B PNPLA2 LRRK1 CPT1B ARG2 SGPL1 PTCD2 TRAPPC9 RBFOX2	1.14e-06	196	122	9	2374_DN
Drug	2,2',4,4',5,6'-hexabromodiphenyl ether	SLCO2B1 SLCO1B3 SLCO1B1	1.49e-06	5	122	3	ctd:C555859
Drug	prednisolone phosphate	SLCO2B1 SLCO1B3 SLCO1B1	2.97e-06	6	122	3	CID000004896
Drug	nateglinide	SLCO2B1 SLCO1B3 SLCO1B1	5.17e-06	7	122	3	ctd:C060142
Drug	NSC263652	SLCO2B1 SLCO1B3 SLCO1B1	8.24e-06	8	122	3	CID000429721
Drug	5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid	SLCO2B1 SLCO1B3 SLCO1B1	1.23e-05	9	122	3	ctd:C000588958
Drug	putrescine	POLB DAO AZIN1 ARG1 ARG2 GRIN3B GAA	1.89e-05	153	122	7	CID000001045
Drug	repaglinide	SLCO2B1 SLCO1B3 SLCO1B1	2.40e-05	11	122	3	ctd:C072379
Drug	17beta-estradiol glucuronide	SLCO2B1 SLCO1B3 SLCO1B1 SLCO2A1	2.51e-05	32	122	4	CID000066424
Drug	AC1L9LRO	ARG1 ARG2	2.85e-05	2	122	2	CID000448254
Drug	2(S)-amino-6-boronohexanoic acid	ARG1 ARG2	2.85e-05	2	122	2	CID009793992
Drug	indospicine	ARG1 ARG2	2.85e-05	2	122	2	CID000108010
Drug	S-2-(Boronoethyl)-L-Cysteine	ARG1 ARG2	2.85e-05	2	122	2	DB03731
Drug	formamidineacetate	ARG1 ARG2	2.85e-05	2	122	2	CID000160693
Drug	Edeine B1	ARG1 ARG2	2.85e-05	2	122	2	CID003085011
Drug	methyl tosylate	ARG1 ARG2	2.85e-05	2	122	2	CID000006645
Drug	(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid	SLCO1B3 SLCO1B1	2.85e-05	2	122	2	ctd:C561635
Drug	1t5f	ARG1 ARG2	2.85e-05	2	122	2	CID005288058
Drug	dinor-N(omega)-hydroxy-L-arginine	ARG1 ARG2	2.85e-05	2	122	2	CID000657087
Drug	2-amino-6-boronohexanoic acid	ARG1 ARG2	2.85e-05	2	122	2	ctd:C121228
Drug	4-guanidino-3-nitrobenzoic acid	ARG1 ARG2	2.85e-05	2	122	2	CID010013854
Drug	glimepiride	SLCO2B1 SLCO1B3 SLCO1B1	3.19e-05	12	122	3	ctd:C057619
Drug	1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one	FKBP9 SHC1 LAMB2 LRRK1 PLXNB2 MTHFD1 EIF4EBP1 CNTNAP4 FGFR3 CAMTA1	3.34e-05	373	122	10	ctd:C540355
Drug	hexabrominated diphenyl ether 153	SLCO2B1 ESR2 SLCO1B3	4.13e-05	13	122	3	ctd:C517828
Drug	CID6426996	SYNPO CPT1B YES1	5.23e-05	14	122	3	CID006426996
Drug	AIAVA	ARG1 ARG2	8.51e-05	3	122	2	CID003080900
Drug	2-AIHA	ARG1 ARG2	8.51e-05	3	122	2	CID000160253
Drug	gamma-hydroxyarginine	ARG1 ARG2	8.51e-05	3	122	2	CID000164980
Drug	2,6-dichlorobenzoate	ARG1 ARG2	8.51e-05	3	122	2	CID000005758
Drug	4 GPa	ARG1 ARG2	8.51e-05	3	122	2	CID003082328
Drug	2-AIPA	ARG1 ARG2	8.51e-05	3	122	2	CID000130171
Drug	Benzocaine [94-09-7]; Up 200; 24.2uM; PC3; HT_HG-U133A	LRRK1 SLCO1B1 AQP4 GREB1L SLCO2A1 CDH4 TRAPPC9	8.58e-05	194	122	7	4224_UP
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	SETD1A CIC GREB1L ZBED4 SH3TC1 PAX2 CDH2	9.75e-05	198	122	7	5213_UP
Drug	copper(II) sulfate pentahydrate; Down 200; 100uM; PC3; HG-U133A	FAM234B HDAC5 PLXNB2 FAAP100 CTSE FOXC1 SLC27A3	9.75e-05	198	122	7	459_DN
Drug	guaifenesin	SLCO2A1 GCA GAA RBFOX2 MASP2	1.06e-04	87	122	5	CID000003516
Drug	gamma-guanidinobutyric acid	ARG1 ARG2 GAA	1.37e-04	19	122	3	CID000000500
Drug	Nitrogen Mustard Compounds	BRCA2 SPRTN CDH2	1.37e-04	19	122	3	ctd:D009588
Drug	kaempferol	SLCO2B1 ESR2 LAMB2 SLCO1B3 SLCO1B1 GREB1	1.54e-04	149	122	6	ctd:C006552
Drug	6-hydroxytetralin	ESR2 YES1	1.70e-04	4	122	2	CID000014305
Drug	phenylphosphorodiamidate	ARG1 ARG2	1.70e-04	4	122	2	CID000081954
Drug	(2-boronoethyl)-cysteine	ARG1 ARG2	1.70e-04	4	122	2	ctd:C425062
Drug	rifamycin SV	SLCO1B3 SLCO1B1	1.70e-04	4	122	2	ctd:C023808
Drug	2b H	ARG1 ARG2	1.70e-04	4	122	2	CID000657085
Drug	malabaricone B	ARG1 ARG2	1.70e-04	4	122	2	CID000163001
Drug	microcystin-LF	SLCO1B3 SLCO1B1	1.70e-04	4	122	2	ctd:C524165
Drug	latanoprost	SLCO2B1 SLCO2A1	1.70e-04	4	122	2	ctd:C072042
Drug	N,N'-bis(3-aminopropyl)cadaverine	ARG1 ARG2	1.70e-04	4	122	2	CID003080781
Disease	response to xenobiotic stimulus	PLBD1 MDGA2 CSMD2 CDH22 CNTNAP4 CDH2 TRAPPC9	1.12e-05	182	122	7	GO_0009410
Disease	puberty onset measurement	SOX6 FNDC3B BIRC6 TNNI3K GLIS2 CAMTA1	1.39e-05	125	122	6	EFO_0005677
Disease	hyperargininemia (implicated_via_orthology)	ARG1 ARG2	1.70e-05	2	122	2	DOID:9278 (implicated_via_orthology)
Disease	HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC	SLCO1B3 SLCO1B1	1.70e-05	2	122	2	C4016905
Disease	Rotor Syndrome	SLCO1B3 SLCO1B1	1.70e-05	2	122	2	C0220991
Disease	Rotor syndrome	SLCO1B3 SLCO1B1	1.70e-05	2	122	2	cv:C0220991
Disease	HYPERBILIRUBINEMIA, ROTOR TYPE	SLCO1B3 SLCO1B1	1.70e-05	2	122	2	237450
Disease	acute graft vs. host disease, donor genotype effect measurement	SLC25A24 MDGA2 SDK1	3.03e-05	15	122	3	EFO_0004599, EFO_0007892
Disease	PR interval	FNDC3B LAMB2 YES1 FAF1 CD93 GET4 UBXN11 GLIS2 CAMTA1 FERMT2	4.16e-05	495	122	10	EFO_0004462
Disease	bilirubin metabolic disorder (implicated_via_orthology)	SLCO1B3 SLCO1B1	1.68e-04	5	122	2	DOID:2741 (implicated_via_orthology)
Disease	Epithelioid hemangioendothelioma	TFE3 CAMTA1	1.68e-04	5	122	2	C0206732
Disease	Ischemic stroke, large artery stroke	SLCO1B1 FAF1	2.52e-04	6	122	2	EFO_0005524, HP_0002140
Disease	bilirubin metabolic disorder (is_implicated_in)	SLCO1B3 SLCO1B1	2.52e-04	6	122	2	DOID:2741 (is_implicated_in)
Disease	gestational age	FAF1 GLIS2 MOV10L1 CAMTA1 SDK1	2.78e-04	138	122	5	EFO_0005112
Disease	Malignant neoplasm of urinary bladder	POLB ESR2 BRCA2 FGFR3 FERMT2	3.07e-04	141	122	5	C0005684
Disease	Spinocerebellar Ataxia Type 2	CIC CWF19L1 FOXC1	3.76e-04	34	122	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	CIC CWF19L1 FOXC1	3.76e-04	34	122	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	CIC CWF19L1 FOXC1	3.76e-04	34	122	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	CIC CWF19L1 FOXC1	3.76e-04	34	122	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	CIC CWF19L1 FOXC1	3.76e-04	34	122	3	C0752124
Disease	Ataxia, Spinocerebellar	CIC CWF19L1 FOXC1	3.76e-04	34	122	3	C0087012
Disease	Spinocerebellar Ataxia Type 4	CIC CWF19L1 FOXC1	4.10e-04	35	122	3	C0752122
Disease	Focal glomerulosclerosis	SYNPO SGPL1 PAX2	4.46e-04	36	122	3	C0017668
Disease	ceramide measurement	ESR2 SLCO1B3 SLCO1B1 SLCO5A1 GRIN3B SDK1	4.48e-04	235	122	6	EFO_0010222
Disease	deoxycholic acid glucuronide measurement	SLCO1B3 SLCO1B1	4.67e-04	8	122	2	EFO_0800575
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP5 CNTNAP4	4.67e-04	8	122	2	DOID:0060308 (implicated_via_orthology)
Disease	hexadecenedioate (C16:1-DC) measurement	SLCO1B3 SLCO1B1	5.99e-04	9	122	2	EFO_0800562
Disease	liver cancer (is_marker_for)	SLCO2B1 SLCO1B1	5.99e-04	9	122	2	DOID:3571 (is_marker_for)
Disease	X-21467 measurement	SLCO1B3 SLCO1B1	5.99e-04	9	122	2	EFO_0020007
Disease	age-related macular degeneration, disease progression measurement	CDH22 SDK1 TRAPPC9	6.55e-04	41	122	3	EFO_0001365, EFO_0008336
Disease	testosterone measurement	SOX6 ESR2 DAO SLCO1B3 R3HDM2 ZNF318 SLCO1B1 PKDREJ BIRC6 FAF1 MTHFD1 FAM157A GREB1 FOXC1	8.13e-04	1275	122	14	EFO_0004908
Disease	Colorectal Neoplasms	ESR2 SLCO1B3 CDH22 SH3TC1 SLCO2A1 FGFR3	1.06e-03	277	122	6	C0009404
Disease	Secondary Open Angle Glaucoma	FNDC3B FOXC1	1.09e-03	12	122	2	C0271148
Disease	Glaucoma, Open-Angle	FNDC3B FOXC1	1.09e-03	12	122	2	C0017612
Disease	cholestasis (biomarker_via_orthology)	SLCO1B3 SLCO1B1 ARG1	1.11e-03	49	122	3	DOID:13580 (biomarker_via_orthology)
Disease	Glaucoma, Primary Open Angle	FNDC3B FOXC1	1.28e-03	13	122	2	C0339573
Disease	glycochenodeoxycholate glucuronide (1) measurement	SLCO1B3 SLCO1B1	1.28e-03	13	122	2	EFO_0800474
Disease	stroke outcome severity measurement	MDGA2 SLCO1B1 CNTNAP4 CDH4	1.31e-03	114	122	4	EFO_0009603
Disease	response to statin	ADGRB3 SLCO1B1 CNTNAP5	1.63e-03	56	122	3	GO_0036273
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	NOL6 MDGA2 BIRC6 TNNI3K CNTNAP5 CDH22 UBE2E1 CAMTA1 SDK1 PLXNA2	1.85e-03	801	122	10	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	pulse pressure measurement	SOX6 FNDC3B ARHGEF12 ZNF318 YES1 PLXNB2 FAF1 PIEZO2 SLC26A7 SLIT3 PTCD2 PAX2 FERMT2 TRAPPC9	1.86e-03	1392	122	14	EFO_0005763
Disease	4-acetamidobutanoate measurement	PLXNB2 MOV10L1	1.96e-03	16	122	2	EFO_0021003
Disease	obesity (implicated_via_orthology)	PNPLA2 ESR2 PLXNB2 SGPL1 SDK1	2.04e-03	215	122	5	DOID:9970 (implicated_via_orthology)
Disease	acute kidney failure (biomarker_via_orthology)	HDAC5 ARG1 ARG2	2.08e-03	61	122	3	DOID:3021 (biomarker_via_orthology)
Disease	smoking behaviour measurement	SOX6 TNNI3K CDH22 CAMTA1 SDK1	2.34e-03	222	122	5	EFO_0005671
Disease	lifestyle measurement, anxiety disorder measurement	RHBDD2 CSMD2 PIEZO2 SDK1	2.56e-03	137	122	4	EFO_0007795, EFO_0010724
Disease	Alzheimer disease, gastroesophageal reflux disease	ADGRB3 CNTNAP5 CAMTA1 CDH4 SDK1	2.63e-03	228	122	5	EFO_0003948, MONDO_0004975
Disease	Bladder Neoplasm	POLB ESR2 FGFR3 FERMT2	2.77e-03	140	122	4	C0005695
Disease	chronic kidney disease (is_marker_for)	SYNPO PAX2	3.07e-03	20	122	2	DOID:784 (is_marker_for)
Disease	Schizophrenia	SETD1A ESR2 DAO CSMD2 AQP4 CACNG8 SLC26A7 MTHFD1 SLIT3 PLXNA2	3.71e-03	883	122	10	C0036341
Disease	cotinine measurement	PAX2 CDH4	4.05e-03	23	122	2	EFO_0007813

Protein segments in the cluster

Peptide	Gene	Start	Entry
GILYLVTPPSVVGGL	AQP4	131	P55087
GGVPILPGNVVQGLY	CAMTA1	731	Q9Y6Y1
PATGTPVVGGLTYRE	ARG2	261	P78540
YPSSPPLVNLETTGG	BIRC6	4636	Q9NR09
RGEVSGQVLSPGYPA	CSMD2	1276	Q7Z408
GNVPVGGILASIYLP	ADGRG4	2596	Q8IZF6
PEGSGVKIISEPGSY	AZIN1	261	O14977
NPEGLSYSTLPGNVI	ADGRB3	1231	O60242
VPETGPAILLDGYSG	GCA	26	P28676
VVLGDGVQLPPGDYS	EIF4EBP1	21	Q13541
LALGGPGQVTYTTPF	CD93	191	Q9NPY3
NPGLISLTGPYLDVG	CACHD1	766	Q5VU97
AAPLLGPEQIYSGGT	CNTNAP4	476	Q9C0A0
PDSIILYGQSIGTVP	ABHD17A	181	Q96GS6
LGLSGYPLTEEEPGT	CRACR2A	441	Q9BSW2
DPIGPLSYTGGVSEL	DMXL2	731	Q8TDJ6
SGSYVALTVQGRPPG	ARHGEF12	136	Q9NZN5
TPATGTPVVGGLTYR	ARG1	241	P05089
GPAYGSPIEQTQVLP	CFAP251	836	Q8TBY9
QSVQGGLPAAGVPVY	R3HDM2	636	Q9Y2K5
PLSGRGGINTYIPLI	RBFOX2	246	O43251
QSIGGVPFYPGITLQ	MPEG1	276	Q2M385
SPYIIPGTQTVTLGG	DAO	226	P14920
PPSLQGVRYVDGGIS	PNPLA2	156	Q96AD5
LSSNGTPVLVDGPIY	FAM171A1	211	Q5VUB5
YILFGPPGTGKTVTI	MOV10L1	766	Q9BXT6
YSIPSNVTNLEGGPG	ESR2	56	Q92731
LLLSGPPQIGKTGAY	GREB1	1341	Q4ZG55
ALGVEGTPGYQAPEI	LRRK1	1421	Q38SD2
GTGGPSTLQYRLLPL	HMCN2	4956	Q8NDA2
GLGYPSLAVGGVTPV	CTSE	186	P14091
VYLSGTESLNEPVPG	CWF19L1	111	Q69YN2
TQSPGTSPLEVLPGY	C9orf131	306	Q5VYM1
QPLGGSTPVEGLTLY	PLXNA2	411	O75051
LEVSYGGSPVPNPGI	PLXNB2	961	O15031
LRTYAGGAVIPTGTP	FAM157A	226	C9JC47
SYAGGVPPTLNEGLE	FOXO4	291	P98177
YPQGLGPTVPELGTE	ISOC2	61	Q96AB3
TVLSDYVGSGPPKGT	PEBP1	101	P30086
EVTTEGYPSEPLGGL	FAM234B	76	A2RU67
PPAQVTVVGSYLLGT	NOL6	156	Q9H6R4
RTYAGGAVIPTGTPE	FAM157C	231	P0CG43
SAQPETPYSGPGLLI	LAMB2	701	P55268
YPQELVVSGPSGDPS	LILRB5	411	O75023
APDGGPYVSGAQIII	GLIS2	341	Q9BZE0
LISYLQTPTEGPVGG	RALGAPA2	1436	Q2PPJ7
PGGQIGEVELSSYTP	FAAP100	166	Q0VG06
SAITYTIPVDQLGPG	FAAP100	561	Q0VG06
LLLTGPPQVGKTGSY	GREB1L	1316	Q9C091
YAISGPTVQGGLPVF	PLBD1	506	Q6P4A8
EGISGQGVYAPPTVR	MDGA2	16	Q7Z553
PVGSYSINGILGIPR	PAX2	181	Q02962
IPPKLAYGNEGVSGV	FKBP9	111	O95302
LALPNGPGVTSTLGY	CCSER2	301	Q9H7U1
GTIVIQYVFPPGVQG	DTX3	236	Q8N9I9
GVIVYISANAGEPGP	CACNG8	176	Q8WXS5
GPYTAQIIPGTGNKL	BRCA2	3201	P51587
ENGYGPSPSGLVSIT	FCRL1	186	Q96LA6
SSRLPPGIIGGEYDQ	FBXO7	436	Q9Y3I1
SVSSPNSLGVVPYLG	FOXC1	6	Q12948
VPPGYISQVIEDSTG	FNDC3B	81	Q53EP0
ISSGQYGEGVPLSPA	CRAMP1	1106	Q96RY5
GIPPASGTGTLQIYL	CDH4	591	P55283
PGRTITVKSYLPGAG	DENND2C	636	Q68D51
GYIIPLQGPGLTTTE	GAA	821	P10253
DLPSGRVEYITGPGV	MASP2	371	O00187
SIPLLGYQVTVGPQG	FGD2	591	Q7Z6J4
ATSGVPVYKVIAPGG	SLC44A5	396	Q8NCS7
GPYIGSVAELSPTGT	CDH22	171	Q9UJ99
VLGPESGTLTSINYP	DCBLD2	76	Q96PD2
ILQSEYGGETIPGPA	FAF1	51	Q9UNN5
GGVDPPIGDVEYLTA	HDAC5	926	Q9UQL6
VEVNGSKVGPDGTPY	FGFR3	291	P22607
LEGPLITPGSGSIYS	FERMT2	166	Q96AC1
QGLYETINVTIPPGT	DNAJA3	366	Q96EY1
VEQGIIPPGKGSQYL	UTP3	251	Q9NQZ2
ITTQSAGGVYTPAGP	SDK1	2186	Q7Z5N4
YTIRPLGVTGVAGEP	POLB	296	P06746
SLTTLLDGLYPGGTP	PKD1L1	2341	Q8TDX9
YVVVTGITPTPLGEG	MTHFD1	371	P11586
GIPPMSGTGTLQIYL	CDH2	581	P19022
IDSDGSGPLGPLQVY	CNTNAP5	606	Q8WYK1
IKNGILRGVYPGSPT	CPT1B	46	Q92523
GSVYQPGELIPTPSG	OTOGL	806	Q3ZCN5
EGYEIPPGGSLVLGQ	PTX4	391	Q96A99
LQILVYPGVGGSGSV	PTCD2	21	Q8WV60
ENGSGPGLYVLPSTV	ODF3L2	41	Q3SX64
EGYGIGLPQNSPLTS	GRIN3B	771	O60391
YIVVSLPPTGEGKGG	TAF6	606	P49848
DGTTYLPGIVGLNNI	USP39	216	Q53GS9
VPPKQTSSYGGLLGN	GET4	286	Q7L5D6
LQPTAVSPPYGGDIS	SYNPO	876	Q8N3V7
TLGTILYLGPQSTVP	PKDREJ	616	Q9NTG1
LGGINIPYTTGPSLT	SLCO5A1	531	Q9H2Y9
GVPKQGSIPYDSVTG	SIAE	236	Q9HAT2
LTPGTGQALRGPLYT	SH3TC1	776	Q8TE82
GSYTPQTVPTGGKAL	SETD1A	186	O15047
RGIGETPIVPLGLSY	SLCO1B1	181	Q9Y6L6
IYASPTIAGSRPGGI	SGPL1	386	O95470
TGFGIIPVGGTYLIQ	SNF8	156	Q96H20
IPVGGTYLIQSVPAE	SNF8	161	Q96H20
PQIPITTGTGVVYPG	SOX6	731	P35712
RVPGGSPLGVSLVYS	CIC	716	Q96RK0
VGINSPLYLGGIPTS	SLIT3	1271	O75094
GIGTVPIQPFGISYV	SLCO2A1	181	Q92959
SYLPGGTTGLQLPST	TFE3	281	P19532
DGPVPGYLSSPQSIT	SLC27A3	266	Q5K4L6
VGGVPIQPFGISYID	SLCO2B1	201	O94956
VNSPGTVYSGALGTP	RHBDD2	336	Q6NTF9
RGIGETPIVPLGISY	SLCO1B3	181	Q9NPD5
PLDVSVTITLGGYQP	PIEZO2	2436	Q9H5I5
KGYVLGETSNLPSPG	SPRTN	256	Q9H040
IIQGPPGTGKTYVGL	ZNFX1	616	Q9P2E3
TDLQVTIEGPEGTPY	UBE2S	41	Q16763
GLYPVTLVGVPQTTG	TRAPPC9	641	Q96Q05
EGDTTEIPGGLPSVY	TBCCD1	476	Q9NVR7
VGGLIAPGPTTAVSY	WLS	31	Q5T9L3
TYGLEVVGHIPQGIP	SLC26A7	281	Q8TE54
STILGPPGSVYEGGV	UBE2E1	81	P51965
GDGSYVSVPSPLGKI	TNNI3K	421	Q59H18
YKGGEEPVTTQPSVG	TEX35	206	Q5T0J7
IPGLSGVLTASEPGY	ZNF318	351	Q5VUA4
SKEGIPGLYRGITPN	SLC25A24	436	Q6NUK1
TPGQYVLTGLQSGQP	SHC1	516	P29353
YGGIGAPVSRQVPAS	UBXN11	56	Q5T124
VPSSYPAGLTGGVTI	YES1	81	P07947
QENGGTGIPPLYSTP	ZBED4	341	O75132